155 related articles for article (PubMed ID: 32728225)
1. Treatment algorithm and prognostic factors for patients with stage I-III carcinoma of the anal canal: a 20-year multicenter study.
Bruyere D; Monnien F; Colpart P; Roncarati P; Vuitton L; Hendrick E; Lepinoy A; Luquain A; Pilard C; Lerho T; Molimard C; Maingon P; Arnould L; Bone-Lepinoy MC; Dusserre L; Martin L; Reynders C; Ancion M; Peiffert D; Leroux A; Hubert P; Delhorme JB; Ghnassia JP; Woronoff AS; Delvenne P; Prétet JL; Bosset JF; Peulen O; Mougin C; Valmary-Degano S; Herfs M
Mod Pathol; 2021 Jan; 34(1):116-130. PubMed ID: 32728225
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
[TBL] [Abstract][Full Text] [Related]
3. Influence of human papillomavirus and p16(INK4a) on treatment outcome of patients with anal cancer.
Koerber SA; Schoneweg C; Slynko A; Krug D; Haefner MF; Herfarth K; Debus J; Sterzing F; von Knebel Doeberitz M; Prigge ES; Reuschenbach M
Radiother Oncol; 2014 Dec; 113(3):331-6. PubMed ID: 25465729
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin.
Williams M; Swampillai A; Osborne M; Mawdsley S; Hughes R; Harrison M; Harvey R; Glynne-Jones R;
Cancer; 2013 Jul; 119(13):2391-8. PubMed ID: 23576077
[TBL] [Abstract][Full Text] [Related]
5. p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: correlation with outcomes following chemo-radiotherapy.
Gilbert DC; Williams A; Allan K; Stokoe J; Jackson T; Linsdall S; Bailey CM; Summers J
Radiother Oncol; 2013 Oct; 109(1):146-51. PubMed ID: 24021343
[TBL] [Abstract][Full Text] [Related]
6. HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma.
Soares PC; Abdelhay ES; Thuler LCS; Soares BM; Demachki S; Ferro GVR; Assumpção PP; Lamarão LM; Ribeiro Pinto LF; Burbano RMR
BMC Gastroenterol; 2018 Feb; 18(1):30. PubMed ID: 29466950
[TBL] [Abstract][Full Text] [Related]
7. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.
Roohipour R; Patil S; Goodman KA; Minsky BD; Wong WD; Guillem JG; Paty PB; Weiser MR; Neuman HB; Shia J; Schrag D; Temple LK
Dis Colon Rectum; 2008 Feb; 51(2):147-53. PubMed ID: 18180997
[TBL] [Abstract][Full Text] [Related]
8. Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.
Oliveira SC; Moniz CM; Riechelmann R; Alex AK; Braghirolli MI; Bariani G; Nahas C; Hoff PM
J Gastrointest Cancer; 2016 Mar; 47(1):75-81. PubMed ID: 26691173
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of human papillomavirus in anal squamous cell carcinoma.
Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG
Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors.
Kapacee ZA; Susnerwala S; Wise M; Biswas A; Danwata F; Scott N
Colorectal Dis; 2016 Nov; 18(11):1080-1086. PubMed ID: 27028038
[TBL] [Abstract][Full Text] [Related]
12. Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.
El-Hadaad HA; Wahba HA; Roshdy S
J Gastrointest Cancer; 2015 Jun; 46(2):156-60. PubMed ID: 25810165
[TBL] [Abstract][Full Text] [Related]
13. A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal.
Eng C; Jácome AA; Das P; Chang GJ; Rodriguez-Bigas M; Skibber JM; Wolff RA; Qiao W; Xing Y; Sethi S; Ohinata A; Crane CH
Clin Colorectal Cancer; 2019 Dec; 18(4):301-306. PubMed ID: 31350201
[TBL] [Abstract][Full Text] [Related]
14. Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma.
Herfs M; Longuespée R; Quick CM; Roncarati P; Suarez-Carmona M; Hubert P; Lebeau A; Bruyere D; Mazzucchelli G; Smargiasso N; Baiwir D; Lai K; Dunn A; Obregon F; Yang EJ; Pauw E; Crum CP; Delvenne P
J Pathol; 2017 Mar; 241(4):522-533. PubMed ID: 27976366
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Relevance of HPV Infection and p16 Overexpression in Squamous Cell Anal Cancer.
Mai S; Welzel G; Ottstadt M; Lohr F; Severa S; Prigge ES; Wentzensen N; Trunk MJ; Wenz F; von Knebel-Doeberitz M; Reuschenbach M
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):819-27. PubMed ID: 26530750
[TBL] [Abstract][Full Text] [Related]
16. Optimal management of squamous cell carcinoma of the anal canal: where are we now?
Eng C; Ahmed S
Expert Rev Anticancer Ther; 2014 Aug; 14(8):877-86. PubMed ID: 24981728
[TBL] [Abstract][Full Text] [Related]
17. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
[TBL] [Abstract][Full Text] [Related]
18. Temporal increase in the incidence of anal squamous cell carcinoma in Kentucky and factors associated with adverse outcomes.
O'brien SJ; Gaskins JT; Ellis CT; Martin BA; Mcdowell J; Gondim DD; Galandiuk S
Cancer Med; 2023 May; 12(10):11462-11474. PubMed ID: 36991580
[TBL] [Abstract][Full Text] [Related]
19. Review of anal cancer patients at the Ottawa hospital.
Abunassar M; Reinders J; Jonker DJ; Asmis T
Eur J Surg Oncol; 2015 May; 41(5):653-8. PubMed ID: 25776438
[TBL] [Abstract][Full Text] [Related]
20. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA
Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
